Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|November 1, 2004
- Volume 0 0
Watch Eating and Drinking Before Bedtime
Advertisement
Research has shown that eatingtoo close to bedtime can impedesleep. Sleep experts have recommendedthat individuals finish eatingat least 2 to 3 hours before their usualbedtime. They said that eating ordrinking too much may make individualsless comfortable when settlingdown for bed. The experts suggestedthe following:
- Avoid a heavy meal too close to bedtime
- Stay away from spicy foods because they may cause heartburn
- Restrict fluids too close to bedtime to prevent nighttime awakenings to use the bathroom
Articles in this issue
almost 22 years ago
Geriatric Pharmacologyalmost 22 years ago
Management of Bacterial Rhinosinusitisalmost 22 years ago
Early RA Treatment Proves Beneficialalmost 22 years ago
Topical Creams Work Temporarilyalmost 22 years ago
Mental Anguish Is Common with Arthritisalmost 22 years ago
Overview of Astrocytomas?The Pharmacist's Perspectivealmost 22 years ago
Scanner Detects Hand Arthritisalmost 22 years ago
OA: All in the Familyalmost 22 years ago
Sheriff Sues Board for Searching His Rx Records Without a Warrantalmost 22 years ago
Restricting the Sale of Cold MedicationsAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
4
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
5